Adding Alarms to Glucose Monitoring: What a 2-Year Study Shows
Research tracking people with Type 1 diabetes who upgraded to an alarm-equipped glucose monitor found meaningful improvements in blood sugar control over two years. Here's what the data revealed.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- People who switched from FreeStyle Libre to FreeStyle Libre 2 (which includes low-blood-sugar alarms) spent significantly less time with dangerously low blood sugar at the 24-month mark.
- The alarm feature was associated with improvements in HbA1c and glucose variability, two key measures of long-term blood sugar management.
- The study followed real-world users in routine clinical practice, making the results applicable to everyday life rather than controlled research settings.
- How much someone benefited was linked to personal factors like years living with diabetes and annual income, suggesting access and experience both play a role.
Why This Study Matters
The ability to catch low blood sugar before it becomes dangerous is one of the most important features of modern glucose monitoring. This study looked at whether adding alarms to a popular flash glucose monitor—FreeStyle Libre 2—actually made a real difference in people's daily lives over the long term.
Researchers followed 93 people with Type 1 diabetes who switched from the original FreeStyle Libre (which has no alarms) to the newer FreeStyle Libre 2 (which alerts users to low and high blood sugars). They tracked outcomes for 24 months after the switch.
What Improved After the Switch
At 24 months, people spent significantly less time with blood sugar readings in the dangerously low range. Time below range 1 (the most dangerous low readings) and time below range 2 (moderately low readings) both improved in statistically meaningful ways.
Beyond low blood sugar, the study also found improvements in HbA1c (a three-month average of blood sugar) and glucose variability—how much someone's blood sugar fluctuates throughout the day. These changes suggest that the alarm feature helped people make better adjustments to their diabetes management.
What the Numbers Tell Us About Differences
Not everyone benefited equally. The study found that people who had lived with Type 1 diabetes longer tended to adjust their insulin doses differently than those newer to diabetes, though both groups saw improvements in time below range.
Annual income was also linked to outcomes. People with higher incomes showed greater improvements in glucose variability and time in the dangerously low range. This finding highlights that access to technology and resources can influence how well someone manages their blood sugar.
Understanding the Real-World Evidence
This was an observational study, meaning researchers tracked what happened in actual clinical practice rather than running a controlled experiment. That makes the results more relevant to everyday life, though it also means other factors beyond the device itself may have contributed to the improvements.
The 24-month timeframe allowed researchers to see whether benefits held up over time, rather than fading after a few months. For people considering an upgrade to an alarm-equipped glucose monitor, this longer-term view offers reassurance that improvements are sustained.
Evidence label
Source: Primary care diabetes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Living With T1DWhat We're Learning About Diabetic Ketoacidosis in Type 1 Diabetes: A French StudyPubMed indexed literature
- Living With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Living With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Living With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Living With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Living With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature